HGH, or recombinant human growth hormone, is a direct replacement therapy primarily studied for conditions like Idiopathic Short Stature (ISS) in children, with ongoing research into long-acting formulations to improve adherence. MK-677, also known as Ibutamoren, is a growth hormone secretagogue (GHS) that stimulates the body's own production of growth hormone. Studies in our corpus suggest MK-677 has been investigated for its potential in addressing age-related decline, improving body composition in older adults, and its effects on bone turnover in obese young men. Both peptides interact with the GH/IGF-1 axis, with HGH directly supplementing growth hormone and MK-677 working to increase its endogenous secretion.
| HGH | MK-677 | |
|---|---|---|
| Drug class | growth hormone | n/a |
| Studies in corpus | 45 | 96 |
| Highest evidence tier | rct | rct |
| Evidence tier mix | rct · 9 other · 11 case series · 1 case report · 3 review · 6 in vitro · 3 preclinical animal · 7 | case report · 4 rct · 10 other · 20 preclinical animal · 29 in vitro · 15 review · 15 |
| Studies with explicit sample size | 7 | 2 |
| Head-to-head studies in corpus | 6 | |
Beyond the literature: here's what third-party Certificate-of-Analysis records (Janoshik, BCC, Auxlabs) say about real HGH and MK-677 batches we've tested. Aggregate, public data — cross-reference against the studies below.
We tested 274 HGH batches across 132 manufacturers, 96.62% avg purity.
We tested 29 MK-677 batches across 24 manufacturers, 98.15% avg purity.
We hold deeper lab coverage on HGH (274 batches tested). MK-677 edges ahead on average measured purity (96.62% vs 98.15%) — a narrow gap; weigh it against failed-batch and underdose counts above.
Studies in our corpus that mention both HGH and MK-677 — the gold-standard direct comparison evidence.
This research strongly suggests that targeting the GH/IGF-1 axis could be a powerful strategy to combat age-related cardiovascular decline and improve vascular health. By restoring endothelial progenitor cell (EPC) function, this approach could enhance the …
This review underscores the critical need for more robust, evidence-based interventions to address somatopause and its associated age-related conditions. The findings highlight that current GH therapy, despite its popularity, lacks sufficient scientific bac…
This comprehensive review underscores the broad therapeutic potential of GHS across multiple organ systems and conditions. The observed benefits, from cardioprotection and growth promotion to metabolic improvements and body composition changes, suggest GHS …
The discovery of capromorelin represents a significant advancement in the development of orally active Growth Hormone Secretagogues (GHSs). Its excellent bioavailability and oral activity directly address a major hurdle in GHS drug development, potentially …
No direct head-to-head trials in our corpus. Indirect comparison only. HGH acts as a direct exogenous source of growth hormone, with studies focusing on its efficacy and safety in conditions like Idiopathic Short Stature, including trials for weekly sustained-release formulations to reduce injection frequency. In contrast, MK-677 functions as an oral growth hormone secretagogue, mimicking ghrelin to stimulate the pituitary gland to release more growth hormone. Research on MK-677 in our corpus includes its exploration for Alzheimer's disease, its potential to restore youthful GH and IGF-I levels in older adults to combat age-related decline, and its effects on bone metabolism in obese young men. While HGH has Phase 3 trial data for ISS in our corpus, MK-677 studies indexed here include RCTs exploring its potential in older adults and its effects on bone turnover, as well as its investigation for Alzheimer's disease. The convenience of MK-677's oral administration is highlighted in some preclinical studies as a significant advantage over injectable therapies.
Looking for vendor-level purity, endotoxin, and HPLC data on HGH or MK-677? TitrateLab tracks Certificate-of-Analysis records from the major peptide labs (Janoshik, BCC, Auxlabs) alongside the research above. Cross-reference vendor batches against the studies on this page.